Earnings · US stocks

Ionis Pharmaceuticals, Inc. (IONS) earnings

Ionis Pharmaceuticals, Inc. published its quarterly report on 2026-11-09. The stock moved -28.13% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-09
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-21.36%—
3 days-28.13%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 8 of them. The stock rose in the 3 trading days after 5 of 8 reports (average -2.35%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-11-09—-0.40+56.81%-28.13%——
2026-07-29-149.40%-0.42+51.70%-6.38%+1.30%-1.61%
2026-04-29—-0.30+60.90%+4.88%+2.15%+0.21%
2026-02-25—-1.15+5.56%-5.03%-12.25%-10.60%
2025-10-29—-0.61+41.81%+0.99%+6.88%+6.80%
2025-07-30—0.85+415.06%+3.74%+54.29%+51.62%
2025-04-30—-0.92+10.39%+9.96%+21.40%+12.92%
2025-02-19-458.30%-0.43+49.03%+1.16%-14.68%-6.42%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: IONS

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.